Regional Anaesthesia For Upper Limb Orthopaedic Surgeries Using Ropivacaine And Dexmedetomidine

â??Dexmeditomidine as an adjuvant to 0.75% Ropivacaine in ultrasound guided Brachial plexus block using supraclavicular parasagittal approach for upper limb orthopedic surgeries:A Randomized Prospective Clinical Study.â??

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/029342

Enrollment

Registered

2020-11-24

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

Control Intervention1: Addition of dexmeditomidine to 0.75% ropivacaine: Group RN receives 0.75% ropivacaine and normal saline Group RD receives 0.75% ropivacaine and dexmeditomidine

Eligibility

Inclusion criteria

Inclusion criteria: Age group 20-60yr ASA 1& 2 Patients undergoing upper limb orthopedic surgeries

Exclusion criteria

Exclusion criteria: Patients with hypersensitivity to local anesthetic Patient refusal Patients with uncontrolled DM, liver disease & renal disease Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Duration of analgesia Onset of sensory & motor block Duration of sensory & motor blockTimepoint: 1,3,6,9,15,30,45,60,90 and 120 minutes and then hourly until recovery is noted	—

Secondary

Measure	Time frame
Haemodynamic variablesTimepoint: 0,5,10,15,30,45,60,90,120,180 minutes intraoperatively, 0,0.5,1,2,4,8,16,24 hours postoperatively	—

Countries

India

Contacts

Public ContactDr Mahima K B

Rajarajeswari Medical College and Hospital

drgskarthik@rediff.com9538220515

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026